Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastrointest Oncol. May 15, 2014; 6(5): 139-144
Published online May 15, 2014. doi: 10.4251/wjgo.v6.i5.139
Published online May 15, 2014. doi: 10.4251/wjgo.v6.i5.139
Table 3 Influence of treatment intent and modality on maximum standardized uptake value and survival
| Factor | Mean SUVmax (95%CI) | Median survival in days (95%CI) |
| Treatment intention | ||
| Curative (n = 182) | 10.6 (9.7, 11.5) | 984 (699, 1269) |
| Palliative (n = 89) | 13.6 (11.9, 15.2) | 370 (332, 408) |
| P = 0.001 | P < 0.001 | |
| Treatment type | ||
| Endoscopic resection (n = 5) | 1.3 (-1.0, 3.6) | Not reached |
| Surgical resection (n = 95) | 10.7 (9.5, 11.9) | 1285 (962, 1608) |
| Chemoradiotherapy (n = 63) | 11.6 (10.0, 13.1) | 700 (411, 988) |
| Palliative (n = 89) | 13.8 (12.1, 15.5) | 370 (349, 390) |
| Exploratory surgery (n = 19) | 8.8 (6.6, 11.0) | 340 (280, 400) |
| P < 0.001 | P < 0.001 |
- Citation: Al-Taan OS, Eltweri A, Sharpe D, Rodgers PM, Ubhi SS, Bowrey DJ. Prognostic value of baseline FDG uptake on PET-CT in esophageal carcinoma. World J Gastrointest Oncol 2014; 6(5): 139-144
- URL: https://www.wjgnet.com/1948-5204/full/v6/i5/139.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v6.i5.139